Seeking Alpha

Biogen-IDEC (BIIB +4.1%) closes at the top of the S&P leader board after ISI Group ups it to...

Biogen-IDEC (BIIB +4.1%) closes at the top of the S&P leader board after ISI Group ups it to Buy, citing a strong pipeline, and noting its new BG-12 multiple-sclerosis pill can double earnings over the next three to four years.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)